[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356275-105":59,"doc-detail-356275-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","dissecting-the-role-of-klf5-from-tumor-progression-to-immune-interactions-with-emphasis-on-glioma-and-bladder-cancer","Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer","","Krüppel-like factor 5 (KLF5) is implicated in tumor development, metastasis, and drug resistance, but its coordinated functions across a broad cancer landscape remain unresolved. This study performs a detailed pan-cancer analysis using multi-omics data from public databases to evaluate KLF5’s clinical associations, prognostic value, mutation and methylation patterns. Results indicate links to malignant pathways and immune-related features, followed by experiments assessing KLF5 as an indicator for glioma and bladder cancer.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dissecting-the-role-of-klf5-from-tumor-progression-to-immune-interactions-with-emphasis-on-glioma-and-bladder-cancer/356275/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dissecting-the-role-of-klf5-from-tumor-progression-to-immune-interactions-with-emphasis-on-glioma-and-bladder-cancer/356275.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study on KLF5?","Question",{"text":112,"@type":113},"To clarify how KLF5 functions across a comprehensive cancer framework, linking tumor progression to immune interactions, with emphasis on glioma and bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and analytical approach were used?",{"text":117,"@type":113},"The study used a detailed pan-cancer analysis with multi-omics data sourced from multiple public databases to assess clinical characteristics, prognosis, mutations, and methylation patterns.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings regarding KLF5?",{"text":121,"@type":113},"KLF5 was implicated in tumor progression and showed prognostic significance across pan-cancer, with associations to malignant pathways and multiple immune-related features.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the study evaluate KLF5 for glioma and bladder cancer?",{"text":125,"@type":113},"Experiments were conducted to test whether KLF5 could serve as a promising indicator for glioma and bladder cancer, supporting its potential diagnostic and therapeutic relevance.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},356275,1790439079,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Original Research PUBLISHED 08 January 2026  \nDOI 10.3389/fimmu.2025.1730356  \nOPEN ACCESS  \nEDITED BY  \nChao Wang,  \nShanghai Jiao Tong University, China  \nREVIEWED BY  \nXiulin Jiang,  \nBeckman Research Institute, United States Xudong Zhu,  \nUniversity of Kentucky, United States Chunhui Wu,  \nUniversity of Groningen, Netherlands  \n*CORRESPONDENCE  \nYanjun Wang  \n [wangyj@sysucc.org.cn](wangyj@sysucc.org.cn)[ ](wangyj@sysucc.org.cn)Zhenqiang He  \n [hezhenq@sysucc.org.cn](hezhenq@sysucc.org.cn)[ ](hezhenq@sysucc.org.cn)Juncheng Luo  \n [luojuncheng@sysush.com](luojuncheng@sysush.com)  \n†These authors have contributed equally to this work  \nRECEIVED 22 October 2025  \nREVISED 04 December 2025  \nACCEPTED 08 December 2025  \nPUBLISHED 08 January 2026  \nCITATION  \nYuan Z, Situ M, Ye Y, Zhang J, Jiang K, Zhang S, Deng X, He Z, Luo J and Wang Y (2026) Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer. Front. Immunol. 16:1730356 .  \ndoi: 10.3389/fimmu.2025.1730356  \nCOPYRIGHT  \n© 2026 Yuan, Situ, Ye, Zhang, Jiang, Zhang, Deng, He, Luo and Wang. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer  \nZe Yuan1†, Minyi Situ 1†, Yimeng Ye 1†, Jinhui Zhang 1†,  \nKuntai Jiang1†, Shingyik Zhang2, Xinpei Deng 1, Zhenqiang He 1*, Juncheng Luo 3* and Yanjun Wang 1*  \n1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China, 2Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China, 3 Department of Neurosurgery, The Seventh Afﬁliated Hospital of Sun Yat-sen University, Shenzhen, China  \nBackground: Krüppel-like factor 5 (KLF5) is involved in various aspects of tumor development, metastasis, and drug resistance through their regulation of transcription and translation, yet its functions in a comprehensive cancer framework are still unclear.  \nMethods: Our research involved a detailed pan-cancer analysis using multiomics data sourced from various public databases. We investigated the clinical characteristics, prognostic signiﬁcance, mutations, and methylation patterns of KLF5 across various cancer types.  \nResults: We discovered that KLF5 is implicated in tumor progression and are prognostic markers across pan-cancer. KLF5 is signiﬁcantly linked to various malignant pathways across different types of cancer. Additionally, KLF5 has associations with several immune-related features. Ultimately, experiments were carried out to investigate whether KLF5 could serve as a promising indicator for glioma and bladder cancer.  \nConclusion: KLF5 may be utilized as a diagnostic tool for cancer, a predictor of its progression, and a guide for treatment., with particular promise as a therapeutic target for glioma and bladder cancer.  \nKEYWORDS  \nKLF5, multi-omics, pan-cancer, prognosis, tumor microenvironment  \n1 Introduction  \nCancer still represents a considerable health challenge, despite signiﬁcant improvements in diagnosis and therapy over the past decades (1) . Increasing cancer rates and deaths are linked to population growth and aging, variations in risk factor prevalence and distribution, and socioeconomic advancements (2) . Consequently,  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nidentifying new biomarkers and molecular indicators is essential for predicting patient outcomes and tailoring treatment strategies.  \nKrüppel-like factor 5 (KLF","cbCaioYy5nJE1hsG","https://ap.wps.com/l/cbCaioYy5nJE1hsG","pdf",15422395,15,"English","# Introduction\n## Pan-cancer background and need for biomarkers\n## Role of KLF5 in cancer biology\n## Multi-omics approach for investigating KLF5\n# Methods\n## Multi-omics pan-cancer analysis\n# Results\n## KLF5 involvement in tumor progression and prognosis\n## Links to malignant pathways and immune-related features\n## Experimental focus on glioma and bladder cancer\n# Conclusion","[{\"question\":\"What was the main objective of the study on KLF5?\",\"answer\":\"To clarify how KLF5 functions across a comprehensive cancer framework, linking tumor progression to immune interactions, with emphasis on glioma and bladder cancer.\"},{\"question\":\"What data and analytical approach were used?\",\"answer\":\"The study used a detailed pan-cancer analysis with multi-omics data sourced from multiple public databases to assess clinical characteristics, prognosis, mutations, and methylation patterns.\"},{\"question\":\"What were the key findings regarding KLF5?\",\"answer\":\"KLF5 was implicated in tumor progression and showed prognostic significance across pan-cancer, with associations to malignant pathways and multiple immune-related features.\"},{\"question\":\"How did the study evaluate KLF5 for glioma and bladder cancer?\",\"answer\":\"Experiments were conducted to test whether KLF5 could serve as a promising indicator for glioma and bladder cancer, supporting its potential diagnostic and therapeutic relevance.\"}]","Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer | PDF",1790124382,38,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb02163112c459be818b0fecac01dd03.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6704acba84d637c5dbcdc2daadd67cd.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f838ecb1fa498caeeb3f98622e3c647d.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56c82e4a3b1446d06788adc96bdc079a.webp",980,1385]